Reading this on a mobile device? Try our optimized mobile version here:

December 28, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • N.Y. considers rules to prevent sepsis deaths
    Following the death of a 12-year-old boy, New York state has proposed regulations requiring that hospitals aggressively look for sepsis in patients to enable earlier treatment. New York could become the first state to adopt such rules. Early symptoms of sepsis can be difficult to distinguish from those of other, less serious maladies, but "[f]irst and foremost, they need to suspect sepsis," the most common cause of death in ICUs, said Dr. Mitchell M. Levy. Treatment includes antibiotics and fluids. The New York Times (tiered subscription model) (12/20) LinkedInFacebookTwitterEmail this Story
NEW Complement Coated C3 Control Cells!
Hemo bioscience has received FDA clearance for its complement coated control cells. Hemo bioscience C3 Control Cells can be used as a control to confirm the efficacy of the AHG reagent used during Direct and Indirect Anti-Globulin tests. For details regarding pricing, manufacturing schedule, and distribution channels email us or call 866-332-2835.

  Science & Health 
  • Cholesterol drug may help children with malaria
    An international team of researchers found that adding the cholesterol drug lovastatin to malaria treatment chloroquine could prevent the late cognitive problems associated with cerebral malaria, according to a mouse model study published in the journal PLoS Pathogens. Lead researcher Dr. Guy Zimmerman of the University of Utah says lovastatin should be added to treatments for malaria. Voice of America (12/27) LinkedInFacebookTwitterEmail this Story
Want More CME/CE Credit from AABB?
Now it's even easier to accomplish your training needs and earn CME/CE credits. Convenient and accessible anytime, the AABB Live Learning Center offers quick access to essential Annual Meeting and audioconference content. Most products offer CME/CE tracking and attendance certification. Click here to get started!

  Emerging Trends 
  Industry News & Practice 
  • Stem cell startup gets support in Wis.
    The Wisconsin Economic Development Corp. has approved tax credits for Regenerative Medical Solutions and several other startups under the Qualified New Business Venture program. Regenerative Medical Solutions develops pancreatic stem cells for use in research on treatments for diabetes. Wisconsin State Journal (Madison) (12/27) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  • Rapid HIV diagnostic test from Chembio gets FDA OK
    The Dual Path Platform HIV 1/2 test from Chembio Diagnostics has gained approval from the FDA. The test is designed to spot antibodies linked to HIV-1/2 in blood or oral fluid samples quickly and at the point of care. RTT News (12/21) LinkedInFacebookTwitterEmail this Story
  Association News 
  • NBF accepting donations to support research grants
    The National Blood Foundation, or NBF, is accepting donations to support research grants and other initiatives that benefit patients and donors. The research grants provide funding for one- or two-year projects in transfusion medicine and cellular therapies. Since 1985, the NBF has awarded more than $7.5 million in grants to 177 scientific investigators to advance the field. All donations are tax-deductible to the fullest extent allowed by law. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Laboratory ManagerCreative Testing SolutionsUS - IL - Chicago
Quality SpecialistBlood Systems, Inc.US - NV - Las Vegas
Laboratory SupervisorCreative Testing SolutionsUS - IL - Chicago
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
LABORATORY MANAGERUnited Blood ServicesUS - NV - Las Vegas
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
West Coast Account ManagerMacopharma USAUS - Nationwide
Director, Patient Blood ManagementAABBUS - MD - Bethesda
Click here to view more job listings.

If all misfortunes were laid in one common heap whence everyone must take an equal portion, most people would be contented to take their own and depart."
Greek philosopher

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2013 SmartBrief, Inc.® Legal Information